Loading...
  • leuprolide acetate
  • LUPRON INJECTION (leuprolide acetate) is indicated in the palliative treatment of advanced prostatic cancer. (rxlist.com)
  • In a comparative trial of LUPRON INJECTION (leuprolide acetate) versus DES , in 5% or more of the patients receiving either drug, the following adverse reactions were reported to have a possible or probable relationship to drug as ascribed by the treating physician. (rxlist.com)
  • In humans, subcutaneous administration of single daily doses of leuprolide acetate results in an initial increase in circulating levels of luteinizing hormone (LH) and follicle stimulating hormone (FSH), leading to a transient increase in levels of the gonadal steroids (testosterone and dihydrotestosterone in males, and estrone and estradiol in pre-menopausal females). (nih.gov)
  • The injection delivers the dose of leuprolide acetate incorporated in a polymer formulation. (nih.gov)
  • thigh
  • 0.3 to 0.5 mg (0.3 mL to 0.5 mL) of undiluted Adrenalin® administered intramuscularly or subcutaneously in the anterolateral aspect of the thigh, up to a maximum of 0.5 mg (0.5 mL) per injection, repeated every 5 to 10 minutes as necessary. (drugs.com)
  • Injection into the anterolateral aspect of the thigh (vastus lateralis muscle) is the most appropriate locations for administration because of its location, size, and available blood flow. (drugs.com)
  • The three best sites for intramuscular injection are the side of the neck, the buttocks and the back of the thigh. (equimed.com)
  • Clostridial
  • Injection into the buttock may not provide effective treatment of anaphylaxis and has been associated with the development of Clostridial injections (gas gangrene). (drugs.com)
  • Additionally, injection into the buttock has been associated with Clostridial infections (gas gangrene). (drugs.com)
  • intramuscularly or subcutaneously
  • Exceeding the highest recommended dosage level of drug per pound of body weight per day, administering more than the recommended number of treatments, and/or exceeding 10 mL intramuscularly or subcutaneously per injection site in adult beef and dairy cattle, and 5 mL intramuscularly per injection site in adult swine, may result in antibiotic residues beyond the withdrawal period. (drugs.com)
  • doses
  • CAM2038 q1w: BPN FluidCrystal® SC injection depot for once weekly administration (50 mg/mL) at doses of 8, 16, 24 and 32 mg (BPN base) (0.16, 0.32, 0.48 or 0.64 mL SC injection). (clinicaltrials.gov)
  • CAM2038 q4w: BPN FluidCrystal® SC injection depot for once monthly administration (356 mg/mL) at doses of 64, 96, 128 or 160 mg (BPN base) (0.18, 0.27, 0.36 or 0.45 mL SC injection). (clinicaltrials.gov)
  • somatropin
  • Somatropin injection is a man-made version of human growth hormone. (drugs.com)
  • Somatropin injection is also used together with a proper diet to treat short bowel syndrome (SBS), which is a condition that prevents the intestine or gut from absorbing food properly. (drugs.com)
  • Appropriate studies performed to date have not demonstrated pediatric-specific problems that would limit the usefulness of somatropin injection in children with growth hormone deficiency. (drugs.com)
  • Appropriate studies have not been performed on the relationship of age to the effects of somatropin injection in children with short bowel syndrome. (drugs.com)
  • Appropriate studies performed to date have not demonstrated geriatric-specific problems that would limit the usefulness of somatropin injection in the elderly. (drugs.com)
  • GENENTECH's Nutropin [somatropin rDNA Human Growth Hormone] and Growth Hormone Injection Delivery Devices for the treatment of growth hormone deficiencies. (antiaginggroup.com)
  • drug
  • Combined, our results indicate appreciable anticancer activity and significant potential for Danshen alcohol extract as a natural antioxidant and herbal human oral cancer chemopreventive drug. (hindawi.com)
  • significantly
  • Here we report our data indicating that Danshen extracts, especially alcohol extract, significantly inhibited the proliferation of the human oral squamous carcinoma (OSCC) cell lines HSC-3 and OC-2. (hindawi.com)